A detailed history of Wells Fargo & Company transactions in 908 Devices Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 11,806 shares of MASS stock, worth $39,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,806
Previous 9,375 25.93%
Holding current value
$39,432
Previous $70,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.0 - $7.24 $12,155 - $17,600
2,431 Added 25.93%
11,806 $60,000
Q1 2024

May 10, 2024

BUY
$6.55 - $9.92 $7,277 - $11,021
1,111 Added 13.44%
9,375 $70,000
Q4 2023

Feb 09, 2024

BUY
$4.96 - $12.41 $6,576 - $16,455
1,326 Added 19.11%
8,264 $92,000
Q3 2023

Nov 13, 2023

SELL
$6.0 - $8.2 $17,298 - $23,640
-2,883 Reduced 29.36%
6,938 $46,000
Q2 2023

Aug 15, 2023

BUY
$5.78 - $10.02 $27,715 - $48,045
4,795 Added 95.4%
9,821 $67,000
Q1 2023

May 12, 2023

BUY
$6.61 - $10.66 $28,905 - $46,616
4,373 Added 669.68%
5,026 $43,000
Q4 2022

Feb 13, 2023

SELL
$7.0 - $17.96 $6,713 - $17,223
-959 Reduced 59.49%
653 $4,000
Q3 2022

Nov 14, 2022

BUY
$15.18 - $24.99 $15,574 - $25,639
1,026 Added 175.09%
1,612 $26,000
Q2 2022

Aug 12, 2022

SELL
$13.3 - $20.74 $61,206 - $95,445
-4,602 Reduced 88.7%
586 $12,000
Q1 2022

May 16, 2022

SELL
$13.18 - $26.28 $77,814 - $155,157
-5,904 Reduced 53.23%
5,188 $98,000
Q4 2021

Feb 14, 2022

BUY
$23.17 - $38.77 $242,891 - $406,425
10,483 Added 1721.35%
11,092 $287,000
Q3 2021

Nov 15, 2021

BUY
$29.99 - $39.13 $4,978 - $6,495
166 Added 37.47%
609 $20,000
Q2 2021

Aug 16, 2021

SELL
$36.7 - $55.11 $99,236 - $149,017
-2,704 Reduced 85.92%
443 $17,000
Q1 2021

May 13, 2021

BUY
$39.94 - $75.0 $125,691 - $236,025
3,147 New
3,147 $153,000

Others Institutions Holding MASS

About 908 Devices Inc.


  • Ticker MASS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,590,200
  • Market Cap $106M
  • Description
  • 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...
More about MASS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.